根据最新提交给美国证券交易委员会（SEC）的文件显示，Microbot Medical Inc（股票代码：MBOT）已与H.C. Wainwright & Co.签订了一项股权分配协议（At-The-Market Offering Agreement）。依据该协议，公司获准在市场上不定期发行并出售总价值最高达3920万美元的普通股股份。
ATM发售机制为上市公司提供了灵活的融资渠道，使其能够根据市场状况和资金需求，择机向公众投资者发售新股。此次协议的签署，意味着Microbot Medical在需要时可利用此渠道筹集资金，以支持其运营及未来发展计划。具体发售的时间、数量和价格将视市场情况而定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.